SAMe 200mg
SAMe 200mg, licence 80000682: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80000682
- Status
- Active licence
- Licence date
- 16 August 2005
- Revision date
- 19 October 2009
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| S-adénosylméthionine Source : Levure | 200.0 mg | Not calculated |
| S-adénosylméthionine Source : Saccharomyces cerevisae | 200.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium végétal, Methacrylic copolymer, cellulose, Acide stéarique, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Comprimé | 3.0 Tous les jours |
| Adultes | Not specified | 1.0 Comprimé | 2.0 Tous les jours |
| Adultes | Not specified | minimum: 2.0 Comprimé ; maximum: 8.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Helps relieve pain due to osetoarthritis. Helps to support a healthy mood balance. Helps to support healthy liver function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist consult a health care practitioner.
- Contre-indications
Do not use if pregnant or breastfeeding, and/or taking antidepressants, hepatoxic drugs, or monoamine oxidase inhibitors. Do not use if diagnosed with bipolar disorder or manic depression. Do not take at night since the product may cause severe anxiety, restlessness and insomnia.
Source
Official Health Canada record, licence 80000682
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2009. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.